Dysgerminoma of the ovary: A retrospective study

Australasian Radiology

Volumn 41, Issue 3, 1997, Pages 262-265

  Reddy, K B ^a   Ahuja, V K ^a   Kannan, V ^a,b   Vallikad, E ^a   Anantha, N ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Dysgerminoma; Ovarian tumour; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; COBALT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINCRISTINE;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; ARTICLE; BIOPSY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COBALT TELETHERAPY; DYSGERMINOMA; FEMALE; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; SALPINGOOOPHORECTOMY; SURVIVAL; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0030803960     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.1997.tb00670.x     Document Type: Article

References (19)

1. Asadourian LA, Taylor HB. Dysgerminoma: An analysis of 105 cases. Obstet. Gynecol. 1969; 33: 370-9.
2. Tewfik HH, Tewfik FA, Latourette HB. A clinical review of seventeen patients with ovarian dysgerminoma. Int. J. Radiat. Oncol. Biol. Phys. 1982; 8: 1705-9.
3. DePalo G, Lattuada A, Kenda R et al. Germ cell tumors of the ovary: The experience of the National Cancer Institute of Milan. I. Dysgerminoma. Int. J. Radiat. Oncol. Biol. Phys. 1987; 13: 853-60.
4. Williams SD, Blessing JA, Hatch KD, Homesley HD. Chemotherapy for advanced dysgerminoma: Trials of the Gynaecologic Oncology Group. J. Clin. Oncol. 1991; 9: 1950-5.
5. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of germ cell tumours with cisplatin, etoposide and bleomycin: A trial of the Gynecologic Oncology Group. J. Clin. Oncol. 1994; 12: 701-6.
6. Gershenson DM. Management of early ovarian cancer: Germcell and sexcord-stromal tumours. Gynecol. Oncol. 1994; 55: S62-72.
7. Teinturier C, Gelez J, Flamant F, Hubrand JL, Lemerle J. Pure dysgerminoma of the ovary in childhood: Treatment results and sequelae. Med. Pediatr. Oncol. 1994; 223: 1-7.
8. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
9. Boyes DA, Pankratz E, Galliford BW, White GW, Fairey RN. Experience with dysgerminoma at the Cancer Control Agency of British Columbia. Gynecol. Oncol. 1978; 6: 123-9.
10. Talerman A, Huyzinga WT, Kupiers T. Dysgerminoma: Clinical pathological study of 22 cases. Obstet. Gynecol. 1973; 41: 137-47.
11. Disaia PJ, Creasman WT. In: Clinical Gynaecologic Oncology. Disaia PJ, Creasman WT (eds). CV Mosby Co., St.Louis, 1989; 417-49.
12. Schwartz PE, Chambers SK, Chambers JT, Kohorn E, McIntosh S. Ovarian germ cell malignancies: The Yale University experience. Gynecol. Oncol. 1992; 45: 26-31.
13. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: A review of 158 cases from the Emil Novak Ovarian Tumour Registry. Obstet. Gynecol. 1981; 58: 497-504.
14. Lucraft HH. A review of thirty three cases of ovarian dysgerminoma emphasizing the role of radiotherapy. Clin. Radiol. 1979; 30: 585-9.
15. Malkasian GG, Symmonds RE. Treatment of the unilateral encapsulated ovarian dysgerminoma. Am. J. Obstet. Gynecol. 1964; 90: 370-82.
16. Brody S. Clinical aspects of dysgerminoma of the ovary. Acta Radiol. 1961; 56: 209-30.
17. Krepart G, Smith JP, Rutledge F, Delclos L. The treatment for dysgerminoma of the ovary. Cancer 1978; 41: 986-90.
18. Thomas GM, Dembo AJ, Hacker NF, DePetrillo AD. Current therapy for dysgerminoma of the ovary. Obstet. Gynecol. 1987; 70: 268-75.
19. Mitchell MF, Gershenson DM, Soeters RP. The long term effects of radiotherapy on patients with ovarian dysgerminoma. Cancer 1991; 67: 1084-90.